High performance chromatography-mass spectrometry (HPLC-MS) Based Lipid Metabolite Profiling of Acromegaly.

CONCLUSION: Patients with acromegaly have distinct lipid metabolite profiling while PE (22:6/16:0) and LysoPC (16:0) are correlated with cardiac structure and function, which may contribute to the risk of cardiovascular complications.
PMID: 31930294 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - January 12, 2020 Category: Endocrinology Authors: Wang M, Guo S, He M, Shao X, Feng L, Yu Y, Gong W, Liu Q, Melnikov V, Wang X, He Z, Jiang L, Chen M, Sun J, Cai J, Zhao Y, Li Y, Tritos NA, Hu Z, Zhang Z Tags: J Clin Endocrinol Metab Source Type: research